IntelyCare
PrivateLast Round
Series C
Apr 6, 2022
Est. Valuation
$1.1B
Total Funding Raised
$174M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
IntelyCare operates in Healthcare & Life Sciences and is based in Quincy, Massachusetts. Its latest recorded funding round was a Series C round in April 2022.
IntelyCare is a healthtech company that provides an AI-powered workforce management platform to connect nursing professionals with per-diem shifts and contract assignments at healthcare facilities.
Sector
Healthcare & Life Sciences
Verticals
HR, Platform-as-a-Service, Workflow Automation, Medical AI
Business Model
B2B
Customer Profile
Marketplace Commission, Subscription SaaS, Services & Consulting
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
IntelyCare Comparables
Compare IntelyCare with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| ShiftMed | 94% | |
| Clipboard Health | 94% | |
| ShiftKey | 92% |
For institutional investors. Book with your work email.
IntelyCare Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series C | Apr 6, 2022 | ||||
| Series B | Feb 20, 2020 | ||||
| Series A | Nov 1, 2018 | ||||
| Seed | Jul 6, 2017 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
IntelyCare Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Longitude Capital | Series C |
| Janus Henderson Group | Series C |
| Kaiser Permanente Ventures | Series B, Series C |
| Generator Ventures | Series B |
| Leeds Illuminate | Series C |
| Longmeadow Capital Partners | Series A |
| Kaiser Foundation Hospitals | Series B, Series C |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 19, 2026
Monthly visitors increased 33% MoM to 214K.
- Jan 8, 2026
Acquired CareRev, an on-demand workforce platform for acute care.
For institutional investors. Book with your work email.
IntelyCare Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about IntelyCare's valuation, stock price, and market status.
Is IntelyCare a public or private company?
IntelyCare is a private company.
What is the current stock price of IntelyCare?
IntelyCare is a private company, so its shares have no public market price. Caplight tracks IntelyCare's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is IntelyCare worth (valuation)?
IntelyCare's valuation is estimated at $1.1B based on funding round data.
Can I buy IntelyCare stock?
IntelyCare shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was IntelyCare's last funding round?
IntelyCare's most recent funding round was Series C on April 6, 2022.
Who are the main investors in IntelyCare?
Key investors in IntelyCare include Janus Henderson Group, Endeavour Vision, Revelation Partners.
Will IntelyCare IPO soon?
No public IPO plans have been announced for IntelyCare.
How can I track IntelyCare secondary market activity?
Caplight tracks bids, offers, and trades in IntelyCare's shares on secondary markets.